Evidence map›Paper›PMID 42900686›Full record

ArticleThe Journal of experimental medicine2026

A genetically regulated SKAP2 switch modulates human T lymphocyte adhesion and migration.

Mara Cetty Spinella, Francesco Gualdrini, Cristina Leoni, Jun Siong Low, Sara Polletti, Amy Kenyon, Samuele Mauri, Veronica Vallelonga, Mehrpouya Mostanfar, Matteo Pecoraro and 14 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Mara Cetty SpinellaInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-2363-3295
Francesco Gualdrini *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-6180-7292
Cristina Leoni *Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-4458-1121
Jun Siong Low *Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-1775-0778
Sara Polletti *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-5433-0502
Amy KenyonDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0001-9248-576X
Samuele MauriInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0009-0009-0488-3107
Veronica VallelongaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0009-0004-2285-2711
Mehrpouya MostanfarInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0003-2624-7063
Matteo PecoraroInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0009-0002-8105-9671
Chiara SorianiDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-4363-6597
Roberta MarziInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-3501-4168
Elena GrassiINOC - Istituto Nazionale Oncologico Candiolo, IRCCS , Candiolo, Italy.ORCID 0000-0003-1066-927X
Fabio BedinDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0009-0006-4313-7762
Elena FoliInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0009-0003-3916-1653
Niccolò BianchiInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0001-5605-3425
Emina DžafoInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0001-8276-858X
Sandra JovicInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0001-6871-8690
Alessandro CuomoDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-9778-7190
Simona RodighieroDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-4236-7823
David JarrossayInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-0924-6395
Federica SallustoInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0003-3750-2752
Gioacchino Natoli *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-0711-2411
Silvia Monticelli *Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-5909-8802

Funding

Ceresio FoundationEuropean Union's Horizon 2020 Research and Innovation Program 733100Horten Health FoundationItalian Ministry of HealthSwiss National Science Foundation 320030_227561
6 · The paper itself

Abstract

Genome-wide association studies investigating autoimmune disorders may reveal previously unrecognized regulators of immune cell functions. A Crohn's disease risk allele was associated with increased expression in T lymphocytes of the adapter protein Src kinase-associated phosphoprotein 2 (SKAP2), whose functional role in these cells is unknown. By analyzing T cells from individuals homozygous for either allelic variant or engineered to modulate SKAP2 endogenous levels, we found that SKAP2 promotes T cell adhesion while restraining migration, acting nonredundantly with its homologue SKAP1. Consistent with such functional differences, SKAP1 and SKAP2 displayed distinct activation-induced regulation as well as unique protein interactomes. Prolonged TCR activation triggered caspase-mediated SKAP2 cleavage, leading to the disassembly of its interactome and enabling a migratory program. Together, these findings identify SKAP2 as a genetically regulated modulator of T cell function whose expression and activity control the balance between adhesion and migration.

Indexed as

Adaptor Proteins, Signal TransducingCell AdhesionCell MovementPhosphoproteinsT-LymphocytesCrohn DiseaseHumansIntracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsPhosphoproteinsSKAP1 protein, humansrc kinase associated phosphoprotein 2

Identifiers

PMID42900686
PMCPMC13682646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.